Cytokinetics, Inc. (CYTK) Tops Q1 EPS by 1c
Tweet Send to a FriendGet Alerts CYTK Hot Sheet
Price: $1.13 -1.74%
Revenue Growth %: -100.0%
Financial Fact:
Research and development revenues from related parties: 328K
Today's EPS Names:
NED, OESX, WSTL, More
Revenue Growth %: -100.0%
Financial Fact:
Research and development revenues from related parties: 328K
Today's EPS Names:
NED, OESX, WSTL, More
Trade CYTK Now!
Cytokinetics, Inc. (NASDAQ: CYTK) reported Q1 EPS of ($0.13), $0.01 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $1.82 million versus the consensus estimate of $1.06 million.
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Cytokinetics, Inc. (CYTK) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Target Corp. (TGT) Misses Q1 Views, Issues Mixed Outlook
- Pacific Sunwear Of California (PSUN) Tops Q1 EPS by 5c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
